ClinicalTrials.govpublic full text
Feasibility Study of Intermediate Doses of ARA-C With Autologous SCT as Consolidation of Low/Intermediate-risk AML
acute myeloid leukemia, chemotherapy, autologous stem cell transplantation, developing country, clinical network, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 912733
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.